Vaxcyte Inc

NASDAQ:PCVX  
34.64
+0.70 (+2.06%)
Earnings Announcements

Vaxcyte Reports Q3 2020 Financial Results

Published: 11/12/2020 22:00 GMT
(PCVX) - Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update.
Vaxcyte Inc- Qtrly Loss per Share $0.41.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.